Bronchial Biopsy Devices Market Size, Share & Trends Analysis Report By Product (Biopsy Forceps, Transbronchial Needle Aspiration Needles, Cytology Brushes, Cryobiopsy Devices), By Region, And Segment Forecasts, 2024 - 2030

Bronchial Biopsy Devices Market Size, Share & Trends Analysis Report By Product (Biopsy Forceps, Transbronchial Needle Aspiration Needles, Cytology Brushes, Cryobiopsy Devices), By Region, And Segment Forecasts, 2024 - 2030

Bronchial Biopsy Devices Market Growth & Trends

The global bronchial biopsy devices market size is expected to reach USD 1.02 billion by 2030, growing at a CAGR of 7.39% from 2024 to 2030, according to a new report by Grand View Research, Inc. One of the major factors contributing to the growth of the market is the rising utilization of bronchial biopsy devices for diagnosing respiratory diseases and the increasing adoption of disposable devices. Moreover, rapid technological advancements and increasing awareness and screening regarding respiratory diseases also contribute to market expansion.

Advancements in medical technology are significantly driving the growth of the market by improving the precision, safety, and effectiveness of diagnostic procedures. Innovations such as EBUS-TBNA enable more accurate sampling of lung tissue, especially in difficult-to-reach areas. These minimally invasive techniques minimize patient discomfort, reduce the risk of complications, and shorten recovery times compared to traditional surgical methods. In addition, companies are entering the market with technologically advanced products to establish a strong presence. For instance, in May 2021, Olympus launched the BF-UC190F endobronchial ultrasound (EBUS) bronchoscope for lung cancer diagnosis and staging, thereby expanding its product portfolio.

Moreover, the increasing awareness and screening initiatives led by various organizations are significantly driving the demand for bronchial biopsy devices. With lung cancer being one of the most prevalent and deadly forms of cancer globally, organizations such as the American Lung Association and the WHO have intensified their efforts to promote early detection and diagnosis. In August 2024, in recognition of World Lung Cancer Day, the Forum of International Respiratory Societies, with the Global Initiative for Asthma as a founding member, emphasized the critical need for increased awareness, early screening, and improved access to lung cancer diagnosis & treatment.

Furthermore, the COVID-19 pandemic had a moderately negative impact on the bronchial biopsy device market, as evidenced by the disruption in lung cancer diagnosis and treatment observed during the early months of the pandemic. According to a study conducted by Elsevier España SLU, in July 2021, at a referral University Hospital in Spain, the mandatory confinement from March 23rd to June 21st, 2020, led to a substantial decrease in the number of lung cancer diagnoses. This decline was attributed to the cancellation or delay of medical consultations, diagnostic tests, and non-essential procedures, which resulted in a reduced number of lung biopsies & screening visits.

Bronchial Biopsy Devices Market Report Highlights

• Based on product, the transbronchial needle aspiration (TBNA) needles segment held the largest revenue share of 62.18% in 2023 and is expected to register growth at the highest CAGR over the forecast period. Moreover, the cryobiopsy devices (cryoprobes) segment is anticipated to grow significantly over the forecast period
• The EBUS-TBNA segment held the largest market share in 2023, as it is a minimally invasive technique that allows for collecting tissue samples from the lungs and surrounding lymph nodes without requiring major surgery
• In 2023, North America dominated the market with a share of over 40%, owing to the robust healthcare infrastructure and rising adoption of innovative diagnostic tools
• Key players in the market are adopting several strategies such as partnership, collaboration, and product launch to expand their offering and increase their market share. For instance, in May 2024, Cook Medical, introduced AcuCore, a next-generation EchoTip AcuCore Endoscopic Ultrasound (EUS) Biopsy Needle in the U.S. It is employed with an ultrasound endoscope for FNB of extramural and submucosal lesions lymph nodes, mediastinal masses, and intraperitoneal masses within the GI tract

Please note The report will be delivered in 2-3 business days upon order notification.